MedPath

A clinical trial to study the effects of Kokilakshadi ghanavati and Kaishora guggulu in patients with joint pain due to the involvement of rakta.

Phase 2
Conditions
Health Condition 1: M109- Gout, unspecified
Registration Number
CTRI/2023/04/051697
Lead Sponsor
Adhip Chand S
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

subjects showing the uric acid level between 7-11 mg/dl.

subjects presenting with clinical features of vatarakta such as,

pain

swelling(katina,stabda)

burning sensation(daha)

malaise

hot to touch

affected skin becomes blackish red in colour(syava/tamra twacha)

itching(kandu)

kunchana(contracture)

daha,toda,sphurana in sandhi

subjects presenting with clinical features of gout such as,

painful joint

swelling

redness of joint

hyperuricemia(7-11 mg/dl)

Exclusion Criteria

subjects prediagnosed with autoimmune disease of joints

patients with chronic alcoholic history

hypothyroidism

patient on immune suppressive drugs

tumour lysis syndrome

type 1 diabetes mellitus

type 2 diabetus mellitus with complications

patients with severe toxicity,ulceration,progressive gangrenous changes

syphilis

patient of vatarakta having,

spread upto knee(aajanu)

cracked skin(sphutita)

broken skin(prabhinna)

discharging(prasruta)

paka

with complications(upadravajushta)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
reduction in serum uric acid level of the patient. <br/ ><br>improvement in signs and symptoms of the patient.Timepoint: assessment of signs and symptoms and serum uric acid level will be done 3 times;0th day,30th day,60th day.
Secondary Outcome Measures
NameTimeMethod
improvement in quality of life of the patient.Timepoint: 2months
© Copyright 2025. All Rights Reserved by MedPath